Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
71%(5 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_3
3
38%
Ph phase_4
4
50%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
4(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Terminated(1)

Detailed Status

Completed7
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (12.5%)
Phase 33 (37.5%)
Phase 44 (50.0%)

Trials by Status

terminated113%
completed788%

Recent Activity

0 active trials
Showing 5 of 8
terminatedphase_3

Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.

NCT00958633
completedphase_2

Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence

NCT02111798
completedphase_4

Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits

NCT04352101
completedphase_4

Connectivity Affecting the Antidepressant REsponse Study

NCT02332291
completedphase_4

Wellbutrin XL for Dysthymic Disorder

NCT00225251
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00958633Phase 3

Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.

Terminated
NCT02111798Phase 2

Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence

Completed
NCT04352101Phase 4

Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits

Completed
NCT02332291Phase 4

Connectivity Affecting the Antidepressant REsponse Study

Completed
NCT00225251Phase 4

Wellbutrin XL for Dysthymic Disorder

Completed
NCT00093288Phase 3

Major Depressive Disorder In The Elderly

Completed
NCT00917059Phase 4

Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)

Completed
NCT00296933Phase 3

Memory Functioning and Antidepressant Treatment

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8